Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware
Complete the form below to unlock access to ALL audio articles.
Rosetta Biosoftware announced today that Eisai Co., Ltd. has licensed the Elucidator® system for differential protein expression analysis and biomarker discovery.
Eisai Co. will be using the Elucidator system in the Laboratory of Seeds Finding Technology to support LC-MS quantification methods for identifying potential neurology biomarkers.
“The Elucidator system will be an important tool for enabling quantitative methods and characterizing cancer proteomes by multidimensional LC-MS/MS,” said Yoshiya Oda, Ph.D., senior scientist at the Laboratory of Seeds Finding Technology.
“We are honored to provide the Elucidator system to this prestigious pharmaceutical company,” said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.
“The Elucidator system supports end-to-end data management and analysis workflow for comparative proteomics, and provides multiple ways for scientists to analyze and refine their data to achieve high-confidence results.”
